Raymond James & Associates Merck & Co., Inc. Transaction History

Raymond James & Associates

$146 Billion
Q1 2024

A detailed history of Raymond James & Associates transactions in Merck & Co., Inc. stock. As of the latest transaction made, Raymond James & Associates holds 9,797,226 shares of MRK stock, worth $1.3 Billion. This represents 0.89% of its overall portfolio holdings.

Number of Shares

9,797,226

Previous 9,587,605 2.19%

Holding current value

$1.3 Billion

Previous $1.05 Billion 23.68%

% of portfolio

0.89%

Previous 0.79%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$113.24 - $131.95 $23.7 Million - $27.7 Million	209,621 Added 2.19%	9,797,226 $1.29 Billion
Q4 2023 Jan 16, 2024	BUY	$100.18 - $109.02 $17.8 Million - $19.4 Million	178,132 Added 1.89%	9,587,605 $1.05 Billion
Q3 2023 Oct 24, 2023	BUY	$102.95 - $114.33 $7.07 Million - $7.85 Million	68,629 Added 0.73%	9,409,473 $969 Million
Q2 2023 Jul 25, 2023	SELL	$108.61 - $118.38 $13.4 Million - $14.6 Million	-123,674 Reduced 1.31%	9,340,844 $1.08 Billion
Q1 2023 Apr 14, 2023	SELL	$102.94 - $114.86 $19.7 Million - $21.9 Million	-191,072 Reduced 1.98%	9,464,518 $1.01 Billion

Q4 2022 Feb 08, 2023	BUY	$87.44 - $112.11 $54.3 Million - $69.6 Million	621,130 Added 6.88%	9,655,590 $1.07 Billion
Q3 2022 Oct 25, 2022	BUY	$84.53 - $94.96 $23 Million - $25.9 Million	272,275 Added 3.11%	9,034,460 $778 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $11.5 Million - $13 Million	-137,864 Reduced 1.55%	8,762,185 $799 Million
Q1 2022 May 11, 2022	BUY	$73.51 - $82.4 $31.1 Million - $34.9 Million	423,594 Added 5.0%	8,900,049 $730 Million
Q4 2021 Feb 08, 2022	SELL	$72.28 - $90.54 $15.7 Million - $19.7 Million	-217,138 Reduced 2.5%	8,476,455 $650 Million
Q3 2021 Nov 02, 2021	BUY	$71.68 - $78.83 $22.5 Million - $24.7 Million	313,402 Added 3.74%	8,693,593 $653 Million
Q2 2021 Aug 11, 2021	BUY	$70.31 - $77.77 $55.4 Million - $61.3 Million	788,235 Added 10.38%	8,380,191 $652 Million
Q1 2021 May 14, 2021	BUY	$68.86 - $81.11 $2.81 Million - $3.31 Million	40,858 Added 0.54%	7,591,956 $585 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $19.7 Million - $21.9 Million	275,133 Added 3.78%	7,551,098 $618 Million
Q3 2020 Nov 04, 2020	BUY	$73.18 - $82.95 $6.65 Million - $7.54 Million	90,860 Added 1.26%	7,275,965 $604 Million
Q2 2020 Jul 28, 2020	BUY	$70.42 - $80.13 $31.4 Million - $35.7 Million	445,684 Added 6.61%	7,185,105 $556 Million
Q1 2020 Apr 21, 2020	BUY	$63.36 - $87.82 $30.9 Million - $42.9 Million	487,961 Added 7.81%	6,739,421 $519 Million
Q4 2019 Feb 12, 2020	BUY	$77.58 - $87.54 $21.1 Million - $23.9 Million	272,561 Added 4.56%	6,251,460 $569 Million
Q3 2019 Nov 07, 2019	BUY	$76.08 - $82.93 $14.4 Million - $15.7 Million	189,697 Added 3.28%	5,978,899 $503 Million
Q2 2019 Aug 06, 2019	BUY	$69.84 - $81.59 $14.4 Million - $16.9 Million	206,650 Added 3.7%	5,789,202 $485 Million
Q1 2019 May 06, 2019	BUY	$69.58 - $79.36 $8.79 Million - $10 Million	126,259 Added 2.31%	5,582,552 $464 Million
Q4 2018 Feb 11, 2019	BUY	$65.24 - $75.71 $9.39 Million - $10.9 Million	143,908 Added 2.71%	5,456,293 $417 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $5.57 Million - $6.55 Million	96,507 Added 1.85%	5,312,385 $377 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $26.2 Million - $30.8 Million	-515,628 Reduced 9.0%	5,215,878 $317 Million
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $20.1 Million - $23.4 Million	394,477 Added 7.39%	5,731,506 $312 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $3.34 Million - $3.99 Million	64,696 Added 1.23%	5,337,029 $300 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $3.62 Million - $3.89 Million	61,635 Added 1.18%	5,272,333 $338 Million
Q2 2017 Aug 14, 2017	BUY	N/A	5,210,698	5,210,698 $334 Million

Others Institutions Holding MRK

# of Institutions

3,765

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $337B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Merck & Co., Inc. Transaction History